title: HCV NS5A 2209-2248 amino acid substitutions affect serum 2,5AS activities.
authors.forename: S
authors.initials: S
authors.lastname: Murashima
authors.forename: R
authors.initials: R
authors.lastname: Kumashiro
authors.forename: T
authors.initials: T
authors.lastname: Ide
authors.forename: M
authors.initials: M
authors.lastname: Sata
mesh_terms: D015088:2',5'-Oligoadenylate Synthetase / Q000097:blood*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D012367:RNA, Viral / Q000737:chemistry*; D012324:RNA-Dependent RNA Polymerase / Q000737:chemistry*; D017361:Viral Nonstructural Proteins / Q000737:chemistry*
chemical_list: D000998:Antiviral Agents; D012367:RNA, Viral; D017361:Viral Nonstructural Proteins; D007372:Interferons; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase; D015088:2',5'-Oligoadenylate Synthetase